ARNOLD C HANISH
CIK 1233253 · Chief Accounting Officer · last filed 2026-01-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$29.84M
Companies
3
Total Filings
49
Lifetime Open-Market Net
-$331.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Director | 5,000 | $0.84 | $4.2K | $65.2K | 18 | 2026-01-02 |
| OMER | Director | 17,400 | $8.73 | $152.0K | -$21.1K | 17 | 2025-07-01 |
| LLY | Chief Accounting Officer | 26,201 | $1133.00 | $29.69M | -$375.5K | 14 | 2012-10-30 |
Recent Filings · Page 2 of 5
49 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-06 | Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Buy (P) | +4,000 | $3.9K | EDGAR |
| 2022-06-06 | Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Buy (P) | +28,000 | $5.2K | EDGAR |
| 2022-06-06 | Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Buy (P) | +4,350 | $5.0K | EDGAR |
| 2022-06-06 | Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Buy (P) | +3,000 | $10.8K | EDGAR |
| 2022-02-14 | OMER | Grant (A) | — | $0 | EDGAR |
| 2022-01-21 | Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-09 | OMER | Exer (M) | +10,000 | $94.4K | EDGAR |
| 2021-08-11 | Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Buy (P) | +7,000 | $6.2K | EDGAR |
| 2020-12-04 | Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-08-24 | Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Buy (P) | +4,000 | $3.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.